Investing in health: the social and economic benefits of health care innovation
A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilizat...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Bingley, U.K.
Emerald
2001
|
Schriftenreihe: | Research in human capital and development
v. 14 |
Schlagworte: | |
Online-Zugang: | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-473 DE-19 DE-355 DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 DE-1046 URL des Erstveröffentlichers |
Zusammenfassung: | A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modelling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning. Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. |
Beschreibung: | 1 Online-Ressource (xvii, 449 Seiten) |
ISBN: | 9781849500708 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV048845333 | ||
003 | DE-604 | ||
005 | 20240104 | ||
007 | cr|uuu---uuuuu | ||
008 | 230306s2001 xx o|||| 00||| eng d | ||
020 | |a 9781849500708 |c £86.95 ; €128.95 ; $154.95 |9 978-1-84950-070-8 | ||
024 | 7 | |a 10.1016/S0194-3960(2001)14 |2 doi | |
035 | |a (ZDB-1-EPB)bslw06339726 | ||
035 | |a (DE-599)BVBBV048845333 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
049 | |a DE-634 |a DE-1043 |a DE-M347 |a DE-523 |a DE-91 |a DE-473 |a DE-19 |a DE-355 |a DE-703 |a DE-20 |a DE-706 |a DE-824 |a DE-29 |a DE-739 |a DE-1046 | ||
245 | 1 | 0 | |a Investing in health |b the social and economic benefits of health care innovation |c edited by Irina Farquhar, Kent Summers, Alan Sorkin |
264 | 1 | |a Bingley, U.K. |b Emerald |c 2001 | |
300 | |a 1 Online-Ressource (xvii, 449 Seiten) | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Research in human capital and development |v v. 14 | |
505 | 8 | |a Can mental health treatment be effectively delivered in primary care? A primer for employee benefit design, decision makers, and an outcome research example / Ralph Swindle, Lisa Harris, Kurt Kroenke, Wansu Tu, X. Zhou -- The interaction of depression and smoking on workplace productivity / Michael Halpern, Zeba Khan, Anne Rentz -- Cost effectiveness in the prevention of suicide : a population approach / Lars von Knorring, Kerstin Bingefors, Lisa Ekselius, Anne-Liis von Knorring, Gunilla Olsson -- Payment effects on resource utilization and outcomes for patients with congestive heart failure / Eugene Kroch, Raj Shah, Douglas Fisher, Evan Loh, J. Sanford Schwartz | |
505 | 8 | |a Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in hiv disease / Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney -- Concomitant illnesses in patients with diabetes : mortality, morbidity, benefits of newer treatments, and individual and societal costs / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Factors influencing patient willingness to pay for diabetes disease state management programs / Jamie Bamer -- Assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility / Tina Stavinoha, Jamie Barner -- Impact of diabetes on human capital and quality of life / Kent Summers, Risa Hayes -- Energy and improved workplace productivity in depression / Ralph Swindle, Kurt Kroenke, LeeAnn Braun -- | |
505 | 8 | |a The frontiers of genetics and the transformation of medicine and business / Robert Field -- Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey / G. Edward Miller, John Moeller -- Pharmaceutical spending and health outcomes in the united states / Pierre-Yves Cremieux, Pierre Ouellette, Marie-Claude Meilleur, Stephanie Leong, Paul Greenberg, Howard Birnbaum -- Too many drugs? The clinical and economic value of incremental innovations / Albert Wertheimer, Richard Levy, Thomas O'Connor -- Factors affecting health services utilization in the medicare population : would providing prescription drug coverage to medicare recipients affect their use of health care resources? / Mary Cifaldi -- Estimating economic cost of HIV/AIDS-related diseases / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- | |
520 | 3 | |a A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modelling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning. | |
520 | 3 | |a Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements | |
520 | 3 | |a Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. | |
650 | 4 | |a Health systems & services | |
650 | 7 | |a Medical |2 Public Health | |
650 | 4 | |a Public health & preventive medicine | |
650 | 7 | |a Social Science |2 Reference | |
650 | 4 | |a Medical care |x Coste effectiveness | |
700 | 1 | |a Farquhar, Irina |e Sonstige |4 oth | |
700 | 1 | |a Sorkin, Alan |e Sonstige |4 oth | |
700 | 1 | |a Summers, Kent |e Sonstige |4 oth | |
856 | 4 | 0 | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-1-EPB | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-034110673 | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-634 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-1043 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-M347 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-523 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-91 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-473 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-19 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-355 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-703 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-20 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-706 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-824 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-29 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-739 |p ZDB-1-EPB |x Verlag |3 Volltext | |
966 | e | |u https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |l DE-1046 |p ZDB-1-EPB |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1821342586209566720 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
building | Verbundindex |
bvnumber | BV048845333 |
collection | ZDB-1-EPB |
contents | Can mental health treatment be effectively delivered in primary care? A primer for employee benefit design, decision makers, and an outcome research example / Ralph Swindle, Lisa Harris, Kurt Kroenke, Wansu Tu, X. Zhou -- The interaction of depression and smoking on workplace productivity / Michael Halpern, Zeba Khan, Anne Rentz -- Cost effectiveness in the prevention of suicide : a population approach / Lars von Knorring, Kerstin Bingefors, Lisa Ekselius, Anne-Liis von Knorring, Gunilla Olsson -- Payment effects on resource utilization and outcomes for patients with congestive heart failure / Eugene Kroch, Raj Shah, Douglas Fisher, Evan Loh, J. Sanford Schwartz Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in hiv disease / Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney -- Concomitant illnesses in patients with diabetes : mortality, morbidity, benefits of newer treatments, and individual and societal costs / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Factors influencing patient willingness to pay for diabetes disease state management programs / Jamie Bamer -- Assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility / Tina Stavinoha, Jamie Barner -- Impact of diabetes on human capital and quality of life / Kent Summers, Risa Hayes -- Energy and improved workplace productivity in depression / Ralph Swindle, Kurt Kroenke, LeeAnn Braun -- The frontiers of genetics and the transformation of medicine and business / Robert Field -- Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey / G. Edward Miller, John Moeller -- Pharmaceutical spending and health outcomes in the united states / Pierre-Yves Cremieux, Pierre Ouellette, Marie-Claude Meilleur, Stephanie Leong, Paul Greenberg, Howard Birnbaum -- Too many drugs? The clinical and economic value of incremental innovations / Albert Wertheimer, Richard Levy, Thomas O'Connor -- Factors affecting health services utilization in the medicare population : would providing prescription drug coverage to medicare recipients affect their use of health care resources? / Mary Cifaldi -- Estimating economic cost of HIV/AIDS-related diseases / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- |
ctrlnum | (ZDB-1-EPB)bslw06339726 (DE-599)BVBBV048845333 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV048845333</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240104</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230306s2001 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781849500708</subfield><subfield code="c">£86.95 ; €128.95 ; $154.95</subfield><subfield code="9">978-1-84950-070-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0194-3960(2001)14</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-1-EPB)bslw06339726</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048845333</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-634</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1046</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Investing in health</subfield><subfield code="b">the social and economic benefits of health care innovation</subfield><subfield code="c">edited by Irina Farquhar, Kent Summers, Alan Sorkin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bingley, U.K.</subfield><subfield code="b">Emerald</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 449 Seiten)</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Research in human capital and development</subfield><subfield code="v">v. 14</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Can mental health treatment be effectively delivered in primary care? A primer for employee benefit design, decision makers, and an outcome research example / Ralph Swindle, Lisa Harris, Kurt Kroenke, Wansu Tu, X. Zhou -- The interaction of depression and smoking on workplace productivity / Michael Halpern, Zeba Khan, Anne Rentz -- Cost effectiveness in the prevention of suicide : a population approach / Lars von Knorring, Kerstin Bingefors, Lisa Ekselius, Anne-Liis von Knorring, Gunilla Olsson -- Payment effects on resource utilization and outcomes for patients with congestive heart failure / Eugene Kroch, Raj Shah, Douglas Fisher, Evan Loh, J. Sanford Schwartz</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in hiv disease / Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney -- Concomitant illnesses in patients with diabetes : mortality, morbidity, benefits of newer treatments, and individual and societal costs / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Factors influencing patient willingness to pay for diabetes disease state management programs / Jamie Bamer -- Assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility / Tina Stavinoha, Jamie Barner -- Impact of diabetes on human capital and quality of life / Kent Summers, Risa Hayes -- Energy and improved workplace productivity in depression / Ralph Swindle, Kurt Kroenke, LeeAnn Braun --</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The frontiers of genetics and the transformation of medicine and business / Robert Field -- Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey / G. Edward Miller, John Moeller -- Pharmaceutical spending and health outcomes in the united states / Pierre-Yves Cremieux, Pierre Ouellette, Marie-Claude Meilleur, Stephanie Leong, Paul Greenberg, Howard Birnbaum -- Too many drugs? The clinical and economic value of incremental innovations / Albert Wertheimer, Richard Levy, Thomas O'Connor -- Factors affecting health services utilization in the medicare population : would providing prescription drug coverage to medicare recipients affect their use of health care resources? / Mary Cifaldi -- Estimating economic cost of HIV/AIDS-related diseases / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir --</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modelling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health systems & services</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical</subfield><subfield code="2">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public health & preventive medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social Science</subfield><subfield code="2">Reference</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="x">Coste effectiveness</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farquhar, Irina</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sorkin, Alan</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Summers, Kent</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-EPB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034110673</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-634</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-1043</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-M347</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-523</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-20</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-706</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-824</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-29</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-739</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV048845333 |
illustrated | Not Illustrated |
index_date | 2024-07-03T21:39:03Z |
indexdate | 2025-01-15T19:00:45Z |
institution | BVB |
isbn | 9781849500708 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034110673 |
open_access_boolean | |
owner | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 DE-1046 |
owner_facet | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 DE-1046 |
physical | 1 Online-Ressource (xvii, 449 Seiten) |
psigel | ZDB-1-EPB |
publishDate | 2001 |
publishDateSearch | 2001 |
publishDateSort | 2001 |
publisher | Emerald |
record_format | marc |
series2 | Research in human capital and development |
spelling | Investing in health the social and economic benefits of health care innovation edited by Irina Farquhar, Kent Summers, Alan Sorkin Bingley, U.K. Emerald 2001 1 Online-Ressource (xvii, 449 Seiten) c rdamedia cr rdacarrier Research in human capital and development v. 14 Can mental health treatment be effectively delivered in primary care? A primer for employee benefit design, decision makers, and an outcome research example / Ralph Swindle, Lisa Harris, Kurt Kroenke, Wansu Tu, X. Zhou -- The interaction of depression and smoking on workplace productivity / Michael Halpern, Zeba Khan, Anne Rentz -- Cost effectiveness in the prevention of suicide : a population approach / Lars von Knorring, Kerstin Bingefors, Lisa Ekselius, Anne-Liis von Knorring, Gunilla Olsson -- Payment effects on resource utilization and outcomes for patients with congestive heart failure / Eugene Kroch, Raj Shah, Douglas Fisher, Evan Loh, J. Sanford Schwartz Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in hiv disease / Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney -- Concomitant illnesses in patients with diabetes : mortality, morbidity, benefits of newer treatments, and individual and societal costs / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Factors influencing patient willingness to pay for diabetes disease state management programs / Jamie Bamer -- Assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility / Tina Stavinoha, Jamie Barner -- Impact of diabetes on human capital and quality of life / Kent Summers, Risa Hayes -- Energy and improved workplace productivity in depression / Ralph Swindle, Kurt Kroenke, LeeAnn Braun -- The frontiers of genetics and the transformation of medicine and business / Robert Field -- Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey / G. Edward Miller, John Moeller -- Pharmaceutical spending and health outcomes in the united states / Pierre-Yves Cremieux, Pierre Ouellette, Marie-Claude Meilleur, Stephanie Leong, Paul Greenberg, Howard Birnbaum -- Too many drugs? The clinical and economic value of incremental innovations / Albert Wertheimer, Richard Levy, Thomas O'Connor -- Factors affecting health services utilization in the medicare population : would providing prescription drug coverage to medicare recipients affect their use of health care resources? / Mary Cifaldi -- Estimating economic cost of HIV/AIDS-related diseases / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modelling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning. Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. Health systems & services Medical Public Health Public health & preventive medicine Social Science Reference Medical care Coste effectiveness Farquhar, Irina Sonstige oth Sorkin, Alan Sonstige oth Summers, Kent Sonstige oth https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Investing in health the social and economic benefits of health care innovation Can mental health treatment be effectively delivered in primary care? A primer for employee benefit design, decision makers, and an outcome research example / Ralph Swindle, Lisa Harris, Kurt Kroenke, Wansu Tu, X. Zhou -- The interaction of depression and smoking on workplace productivity / Michael Halpern, Zeba Khan, Anne Rentz -- Cost effectiveness in the prevention of suicide : a population approach / Lars von Knorring, Kerstin Bingefors, Lisa Ekselius, Anne-Liis von Knorring, Gunilla Olsson -- Payment effects on resource utilization and outcomes for patients with congestive heart failure / Eugene Kroch, Raj Shah, Douglas Fisher, Evan Loh, J. Sanford Schwartz Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in hiv disease / Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney -- Concomitant illnesses in patients with diabetes : mortality, morbidity, benefits of newer treatments, and individual and societal costs / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Factors influencing patient willingness to pay for diabetes disease state management programs / Jamie Bamer -- Assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility / Tina Stavinoha, Jamie Barner -- Impact of diabetes on human capital and quality of life / Kent Summers, Risa Hayes -- Energy and improved workplace productivity in depression / Ralph Swindle, Kurt Kroenke, LeeAnn Braun -- The frontiers of genetics and the transformation of medicine and business / Robert Field -- Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey / G. Edward Miller, John Moeller -- Pharmaceutical spending and health outcomes in the united states / Pierre-Yves Cremieux, Pierre Ouellette, Marie-Claude Meilleur, Stephanie Leong, Paul Greenberg, Howard Birnbaum -- Too many drugs? The clinical and economic value of incremental innovations / Albert Wertheimer, Richard Levy, Thomas O'Connor -- Factors affecting health services utilization in the medicare population : would providing prescription drug coverage to medicare recipients affect their use of health care resources? / Mary Cifaldi -- Estimating economic cost of HIV/AIDS-related diseases / Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir -- Health systems & services Medical Public Health Public health & preventive medicine Social Science Reference Medical care Coste effectiveness |
title | Investing in health the social and economic benefits of health care innovation |
title_auth | Investing in health the social and economic benefits of health care innovation |
title_exact_search | Investing in health the social and economic benefits of health care innovation |
title_exact_search_txtP | Investing in health the social and economic benefits of health care innovation |
title_full | Investing in health the social and economic benefits of health care innovation edited by Irina Farquhar, Kent Summers, Alan Sorkin |
title_fullStr | Investing in health the social and economic benefits of health care innovation edited by Irina Farquhar, Kent Summers, Alan Sorkin |
title_full_unstemmed | Investing in health the social and economic benefits of health care innovation edited by Irina Farquhar, Kent Summers, Alan Sorkin |
title_short | Investing in health |
title_sort | investing in health the social and economic benefits of health care innovation |
title_sub | the social and economic benefits of health care innovation |
topic | Health systems & services Medical Public Health Public health & preventive medicine Social Science Reference Medical care Coste effectiveness |
topic_facet | Health systems & services Medical Public health & preventive medicine Social Science Medical care Coste effectiveness |
url | https://www.emerald.com/insight/publication/doi/10.1016/S0194-3960(2001)14 |
work_keys_str_mv | AT farquharirina investinginhealththesocialandeconomicbenefitsofhealthcareinnovation AT sorkinalan investinginhealththesocialandeconomicbenefitsofhealthcareinnovation AT summerskent investinginhealththesocialandeconomicbenefitsofhealthcareinnovation |